TABLE 4A.
Prognosis of Non-Hodgkin’s Lymphoma Patients Treated by Combined Method of TBI Followed by Local Irradiation (Takai et al., 1991; Takai, 1992)
| Age/sex | Stage | Primary site | Treatment method | Response | Survival, months | Present status | Recurrence |
|---|---|---|---|---|---|---|---|
| 27/M | II | Neck | TBI+Local-Chemo | CR | 51 | Alive | No |
| 64/M | III | Tonsil | TBI-Chemo | CR | 49 | Alive | No |
| 60/M | II | Tonsil | TBI+Local-Chemo | CR | 46 | Alive | No |
| 70/F | I | Tonsil | TBI+Local-Chemo | CR | 28 | Alive | No |
| 65/F | II | Tonsil | TBI+Local-Chemo | CR | 29 | Alive | No |
| 55/M | III | Tonsil | TBI+Local-Chemo | CR | 14 | Dead | Yes |
| 73/F | IV | Neck | TBI+Local-Chemo | CR | 13 | Dead | Yes |
| 62/M | II | Neck | TBI+Local-Chemo | CR | 25 | Alive | No |
| 32/M | IV | Neck | TBI-Chemo | PR | 22 | Alive | No |
| 61/F | I | Nasal cavity | TBI+Local-Chemo | CR | 8 | Alive | No |
| 54/M | III | Tonsil | TBI+Local-Chemo | CR | 2 | Alive | No |
Chemotherapy followed a few months later as a boost therapy after completing radiotherapy. CR: complete response, PR: partial response. Survival results observed in 1995.